Showing results (21-30 of 1,875) with videos related to

Sort By:
Pageof 188
Therapeutic Advances in Medical Oncology|December 26, 2022
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysisHisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectivesSilvia Vanni, Alessandro De Vita, Lorena Gurrieri, et al.
Therapeutic Advances in Medical Oncology|June 13, 2022
Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated gliomaSantiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Vanesa García-Barberán, et al.
Therapeutic Advances in Medical Oncology|June 24, 2022
Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: a prospective cohort studyChien-Jui Huang, Wen-Yen Huang, Chien-Yu Chen, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancerZhuangzhuang Zheng, Chenbin Bian, Huanhuan Wang, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of ViennaPhilipp Melhorn, Elisabeth Kretschmer-Chott, Ladislaia Wolff, et al.
Therapeutic Advances in Medical Oncology|June 20, 2022
Erratum to "The utility of cfDNA in TGCT patient management: a systematic review"
Therapeutic Advances in Medical Oncology|May 21, 2019
Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer DatabaseMax Seaton, Andrew Hanna, Cherif Boutros, et al.
Pageof 188